CRISIL reaffirms ‘BBB/Stable/CRISIL A3+’ ratings on Savla Chemicals
These strengths are partially offset by susceptibility of profit margins to volatility in raw material prices and moderate scale of operations.
These strengths are partially offset by susceptibility of profit margins to volatility in raw material prices and moderate scale of operations.
The acquisition of CAME will enable Azelis to expand its field of activities into the friction market and it will strengthen its presence in CASE, personal care and rubber & plastic additives (R&PA)
The company has posted net profit of Rs.220.46 crores for the 9 months period ended December 31, 2020.
The stored energy in the charging station can be used to charge portable electronic devices such as mobile phones, laptops, tablets, and power banks using various charging ports provided in the station.
This is the first patent for UFlex's chemicals business in India and the company will be considering applying for a global patent in due course of time.
This is a step towards India’s commitment towards infrastructure development of ?Shahid Beheshti Port of Chabahar.
This project will be the first of its kind to use waste tires as feedstock for low-carbon, low-sulfur fuel production
The proposed combination of AkzoNobel and Tikkurila would create a strong platform for future growth, better able to serve customers with more innovative and sustainable solutions, building on a shared European heritage
Around 33 women participated in the program.
The company has commissioned 2 lines of PVC pipe and 1 line of HDPE/Sprinkler pipe.
The company registered a net profit of Rs. 11.37 crore in Q3FY21
The company has posted net profit of Rs.13.93 crores for the 9 months period ended December 31, 2020
The company has posted net profit of Rs.15.29 crores for the 9 months period ended December 31, 2020.
The Board of Directors has also appointed R. K. Jain as an Additional Director with effect from January 14, 2021.
This AI laboratory will be the first of its kind in Europe to apply AI to full-scale biomanufacturing from microbial strain development to process optimization and scheduling.
The joint venture will manufacture hydrogen at the refinery for use across the HyNet region.
With a mix of vaccines targeting different stages of COVID-19, the company is eyeing huge market potential
Hybrid electric vehicles to be supplied with below zero carbon intensity biofuel
The phase 3 clinical trial of Sputnik V will be conducted on 1,500 subjects as part of the randomized, double blind, parallel group placebo controlled study in India.
In the joint venture (JV), Aarvi Encon FZE would own 70 percent controlling stake and the local owner at Oman would own the balance 30 percent minority stake.
Subscribe To Our Newsletter & Stay Updated